PET and SPECT Functional Imaging

PET & SPECT Principles - Nuclear Twins

• Shared Foundation: Both are nuclear medicine techniques visualizing physiological function using radiotracers.
• SPECT (Single Photon Emission Computed Tomography):
  • Radiotracers: Gamma emitters (e.g., $^{99m}$Tc, $^{123}$I, $^{67}$Ga). Longer half-lives.
  • Detection: Single photons via gamma camera with physical collimators for localization.
  • Resolution: Generally lower than PET.
  • 📌 Mnemonic: Single Photon.
• PET (Positron Emission Tomography):
  • Radiotracers: Positron emitters (e.g., $^{18}$F, $^{11}$C, $^{13}$N, $^{15}$O). Shorter half-lives.
  • Detection: Positron annihilates with electron, emits two 511 keV photons at ≈180°. Electronic collimation via coincidence detection.
  • Resolution: Generally higher than SPECT.
  • 📌 Mnemonic: Positron, Pair (of photons).

⭐ The fundamental principle of PET imaging relies on the near-simultaneous detection of two 511 keV annihilation photons originating from a single positron-electron interaction event. This allows for electronic collimation and superior image quality compared to SPECT for many applications.

Radiopharmaceuticals & Tracers - Tracer Tales

• PET Tracers (Positron Emitters):
  • $^{18}$F-FDG (Fluorodeoxyglucose): Glucose analog; oncology, neuro, cardio. 📌 FDG: "Finds Damned Growths".
  • $^{68}$Ga-DOTATATE/NOC/TOC: Somatostatin receptors (NETs).
  • $^{18}$F-PSMA: Prostate cancer.
  • $^{13}$N-Ammonia (myocardial perfusion), $^{15}$O-Water (cerebral flow), $^{11}$C-Methionine (amino acid metabolism).
• SPECT Tracers (Gamma Emitters):
  • $^{99m}$Tc (Technetium-99m) based:
    • MDP/HDP: Bone scans.
    • Sestamibi/Tetrofosmin: Myocardial perfusion, parathyroid.
    • HMPAO/ECD: Cerebral blood flow.
    • MAA: Lung perfusion.
    • DMSA: Renal cortex.
    • MAG3: Renal function.
  • $^{123}$I / $^{131}$I: Thyroid ($^{131}$I also therapy).
  • $^{111}$In-Octreotide: NETs.
  • $^{67}$Ga-Citrate: Inflammation, lymphoma.
  • $^{201}$Tl-Chloride: Myocardial perfusion, tumors.
• Principle: Radiotracers target specific physiological processes or molecular targets.

  ⭐ $^{18}$F-FDG is the most widely used PET tracer, crucial for cancer staging due to high glucose uptake by malignant cells (Warburg effect).

Oncologic & Cardiac Applications - Scan Savvy

Oncology (Primarily $^{18}F-FDG$ PET/CT):

• Core Uses: Staging, restaging, therapy response, recurrence, biopsy guidance.
• Key Metric: Standardized Uptake Value (SUV); $SUV_{max}$ reflects max tumor metabolic activity. ↑ uptake in active tissues.
• Common Cancers: Lymphoma, lung, colorectal, breast, melanoma, H&N.

  ⭐ FDG-PET/CT often detects occult metastases missed by conventional imaging, changing management in up to 30% of cases.

• Pitfalls: Inflammation, infection (false +ve); low-grade/small tumors, hyperglycemia (false -ve).

Cardiology:

• Myocardial Viability: Differentiates hibernating/stunned myocardium from scar. Guides revascularization.
  • PET ($^{18}F-FDG$): Glucose metabolism. Gold standard. "Mismatch" pattern (↓perfusion, preserved FDG) = viable.
  • SPECT ($^{201}Tl$, $^{99m}Tc$-Sestamibi/Tetrofosmin): Perfusion & cell integrity.
• Myocardial Perfusion: SPECT (dominant), PET ($^{82}Rb$, $^{13}N-NH_3$). Detects ischemia/infarction.
• Inflammation/Infection ($^{18}F-FDG$ PET): Cardiac sarcoidosis, endocarditis, device infections.

Neurologic & Other Applications - Brain & More

• Dementias:
  • Alzheimer's: FDG-PET (↓ temporoparietal metabolism), Amyloid PET, Tau PET.

    ⭐ Alzheimer's (FDG-PET): Classic bilateral posterior cingulate & temporoparietal hypometabolism.

  • Frontotemporal Dementia (FTD): FDG-PET (↓ frontal/anterior temporal metabolism).
  • Lewy Body Dementia (LBD): DAT-SPECT (↓ striatal uptake); FDG-PET (↓ occipital metabolism, "cingulate island sign").
• Epilepsy:
  • Ictal SPECT: ↑ perfusion at seizure focus.
  • Interictal FDG-PET: ↓ metabolism at seizure focus.
• Parkinson's Disease: DAT-SPECT (Ioflupane $^{123}\text{I}$): ↓ striatal dopamine transporter uptake.
• Brain Tumors:
  • FDG-PET: Differentiates recurrence vs. radiation necrosis; tumor grading.
  • Amino Acid PET (e.g., $^{18}\text{F-FET}$): Better tumor delineation.
• Other Key Uses:
  • FDG-PET: Fever of Unknown Origin (FUO), vasculitis, active sarcoidosis.
  • Bone SPECT: Occult fractures (#), osteomyelitis, prosthesis issues.
  • Neuroendocrine Tumors (NETs): $^{68}\text{Ga-DOTATATE}$ PET/CT.

oka

• PET: Uses positron emitters (e.g., ¹⁸F-FDG), detects 511 keV annihilation photons.
• SPECT: Employs gamma emitters (e.g., ⁹⁹mTc), requires collimators.
• ¹⁸F-FDG PET is crucial for oncology (staging, response), neurology (dementia), cardiac viability.
• SPECT applications include myocardial perfusion, bone scans, thyroid imaging.
• PET generally provides higher spatial resolution and sensitivity over SPECT.
• Hybrid imaging (PET/CT, SPECT/CT) integrates functional data with anatomical localization.
• Common PET tracers: ¹⁸F-FDG (glucose metabolism), ⁶⁸Ga-DOTATATE (NETs), ⁶⁸Ga-PSMA (prostate).